AstraZeneca, Jubilant Biosys Join Hands For Leads In Neuroscience
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Collaborative research between Indian and multinational drug companies gained further ground as Jubilant Biosys signed an agreement with AstraZeneca for delivering novel drug candidates to strengthen its preclinical pipeline. Based out of Bangalore, Jubilant Biosys is the research arm of Jubilant Organosys